Shijiazhuang Yiling Pharmaceutical Dividends and Buybacks
Dividend criteria checks 2/6
Shijiazhuang Yiling Pharmaceutical is a dividend paying company with a current yield of 1.84%.
Key information
1.8%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 1.8% |
| Dividend Growth | 15.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.300 |
| Payout ratio | 338% |
Recent dividend and buyback updates
Recent updates
Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s (SZSE:002603) Business Is Trailing The Industry But Its Shares Aren't
Nov 26
Shijiazhuang Yiling Pharmaceutical's (SZSE:002603) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 04Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Using Too Much Debt?
Sep 25Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s (SZSE:002603) Subdued P/S Might Signal An Opportunity
Aug 07Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Has Announced That Its Dividend Will Be Reduced To CN¥0.30
Jul 15Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) A Risky Investment?
May 26Weak Statutory Earnings May Not Tell The Whole Story For Shijiazhuang Yiling Pharmaceutical (SZSE:002603)
May 05Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) Analysts Just Cut Their EPS Forecasts Substantially
May 02Should You Be Adding Shijiazhuang Yiling Pharmaceutical (SZSE:002603) To Your Watchlist Today?
Mar 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002603's dividend payments have been volatile in the past 10 years.
Growing Dividend: 002603's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Shijiazhuang Yiling Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002603) | 1.8% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (002603) (up to 3 years) | 1.8% |
Notable Dividend: 002603's dividend (1.84%) is higher than the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 002603's dividend (1.84%) is low compared to the top 25% of dividend payers in the CN market (2.09%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (337.5%), 002603's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 002603 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 18:26 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shijiazhuang Yiling Pharmaceutical Co., Ltd. is covered by 19 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhengwu Wu | AJ Securities Co., Ltd |
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Weiying Tu | China International Capital Corporation Limited |